WATCH: Advocates Urge Congress to Increase Access to Innovative Diagnostics
Effectively treating a disease begins with an accurate diagnosis, but current Medicare reimbursement policy limits patient access to many innovative diagnostic radiopharmaceuticals that can diagnose and monitor conditions such as Parkinson’s disease, advanced cardiac disease, cancers of the prostate, breast, and brain. The technology has also been integral to validating an Alzheimer’s diagnosis for many patients, like Geri Taylor, by confirming the presence of amyloid plaques in the brain.
Watch as Geri’s husband, Jim, talks about why Congressional action is needed to improve access to these critical drugs:
Please join Jim, Geri and countless other advocates in asking Congress to pass the Facilitating Innovative Nuclear Diagnostics (FIND) Act and give clinicians all the tools necessary to diagnose Alzheimer’s disease and many others.
More Articles
March is National Colorectal Cancer Awareness Month
Nineteen years ago, President Clinton declared March as National Colorectal Cancer Awareness Month. Increases in colorectal cancer screening have…
Read MorePhysician Spotlight: Dr. Robert Pugach
Fate took an interesting turn when I was diagnosed with prostate cancer in late 2016. For almost three decades I…
Read MorePatient Leaders Visit Capitol Hill
Last week, patient leaders joined Right Scan Right Time for a Capitol Hill fly-in! These delegates from Alabama,…
Read MoreElection Update: What the Midterms Mean for Medical Imaging
The midterm elections are over, finally! While Democrats managed to regain leadership of the House, Republicans picked up three seats…
Read More